Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bruker Corporation (BRKR : NSDQ)
 
 • Company Description   
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.

Number of Employees: 11,396

 
 • Price / Volume Information   
Yesterday's Closing Price: $36.20 Daily Weekly Monthly
20 Day Moving Average: 3,820,479 shares
Shares Outstanding: 151.72 (millions)
Market Capitalization: $5,492.24 (millions)
Beta: 1.20
52 Week High: $64.64
52 Week Low: $28.53
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 12.74% 11.54%
12 Week -9.30% -13.54%
Year To Date -38.25% -45.55%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
40 Manning Road
-
Billerica,MA 01821
USA
ph: 978-663-3660
fax: 978-663-5585
investor.relations@bruker.com http://www.bruker.com
 
 • General Corporate Information   
Officers
Frank H. Laukien - President; Chief Executive Officer and Chairman
Gerald N. Herman - Executive Vice President and Chief Financial Offic
Thomas Bures - Chief Accounting Officer
Bonnie H. Anderson - Director
Cynthia Friend - Director

Peer Information
Bruker Corporation (DNEX)
Bruker Corporation (T.PUR)
Bruker Corporation (CALP.)
Bruker Corporation (CCSI.)
Bruker Corporation (NEWP.)
Bruker Corporation (PBSC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: INSTRU-SCIENTFC
Sector: Computer and Technology
CUSIP: 116794108
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/04/25
Share - Related Items
Shares Outstanding: 151.72
Most Recent Split Date: (:1)
Beta: 1.20
Market Capitalization: $5,492.24 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.55%
Current Fiscal Quarter EPS Consensus Estimate: $0.86 Indicated Annual Dividend: $0.20
Current Fiscal Year EPS Consensus Estimate: $1.98 Payout Ratio: 0.09
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.01
Estmated Long-Term EPS Growth Rate: 3.61% Last Dividend Paid: 09/23/2025 - $0.05
Next EPS Report Date: 11/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.27
Trailing 12 Months: 16.84
PEG Ratio: 5.07
Price Ratios
Price/Book: 3.02
Price/Cash Flow: 10.08
Price / Sales: 1.60
EPS Growth
vs. Year Ago Period: -38.46%
vs. Previous Quarter: -31.91%
Sales Growth
vs. Year Ago Period: -0.41%
vs. Previous Quarter: -0.50%
ROE
09/30/25 - -
06/30/25 - 17.89
03/31/25 - 19.47
ROA
09/30/25 - -
06/30/25 - 5.38
03/31/25 - 5.95
Current Ratio
09/30/25 - -
06/30/25 - 1.61
03/31/25 - 1.57
Quick Ratio
09/30/25 - -
06/30/25 - 0.70
03/31/25 - 0.74
Operating Margin
09/30/25 - -
06/30/25 - 9.45
03/31/25 - 10.26
Net Margin
09/30/25 - -
06/30/25 - 2.31
03/31/25 - 2.31
Pre-Tax Margin
09/30/25 - -
06/30/25 - 3.98
03/31/25 - 4.65
Book Value
09/30/25 - -
06/30/25 - 11.99
03/31/25 - 12.10
Inventory Turnover
09/30/25 - -
06/30/25 - 1.54
03/31/25 - 1.54
Debt-to-Equity
09/30/25 - -
06/30/25 - 1.31
03/31/25 - 1.13
Debt-to-Capital
09/30/25 - -
06/30/25 - 57.15
03/31/25 - 53.33
 

Powered by Zacks Investment Research ©